The present invention generally pertains to microsurgical systems and more particularly to controlling intraocular pressure in ophthalmic surgery.
During small incision surgery, and particularly during ophthalmic surgery, small probes are inserted into the operative site to cut, remove, or otherwise manipulate tissue. During these surgical procedures, fluid is typically infused into the eye, and the infusion fluid and tissue are aspirated from the surgical site.
Maintaining an optimum intraocular pressure during ophthalmic surgery is currently problematic. When no aspiration is occurring, the pressure in the eye becomes the pressure of the fluid being infused into the eye. This pressure is typically referred to as the “dead head pressure”. However, when aspiration is applied, the intraocular pressure drops dramatically from the dead head pressure due to all the pressure losses in the aspiration circuit associated with aspiration flow. Therefore, ophthalmic surgeons currently tolerate higher than desired dead head pressures to compensate for occasions when aspiration would otherwise lower the intraocular pressure to soft-eye conditions. Clinically, such over-pressurizing of the eye is not ideal.
Accordingly, a need continues to exist for improved apparatus for controlling intraocular pressure during ophthalmic surgery.
In one aspect, the present invention is a surgical cassette including a dual infusion chamber and first through fifth fluid lines. The dual infusion chamber has a first chamber not fluidly coupled to the second chamber. The first fluid line is fluidly coupled to the first chamber and is for providing an irrigating fluid to the first chamber. The second fluid line is fluidly coupled to the first chamber and is for providing the irrigating fluid to a surgical device. The third fluid line is fluidly coupled to the second chamber and is for providing the irrigating fluid to the second chamber. The fourth fluid line is fluidly coupled to the second chamber and is for providing the irrigating fluid to the surgical device. The fifth fluid line is fluidly coupled to one of the first chamber or the second chamber and is for providing the irrigating fluid to one of the first chamber or the second chamber.
For a more complete understanding of the present invention, and for further objects and advantages thereof, reference is made to the following description taken in conjunction with the accompanying drawings, in which:
The preferred embodiments of the present invention and their advantages are best understood by referring to
Infusion source 14 is preferably a flexible infusion source. As shown best in
In operation, fluid lines 70, 72, and 74; chambers 16a and 16b; fluid lines 76, 78, and 80; and surgical device 29 are all primed with a surgical irrigating fluid 140 by pressurizing infusion source 14. Surgical irrigating fluid 140 may be any surgical irrigating fluid suitable for ophthalmic use, such as, by way of example, BSS PLUS® intraocular irrigating solution available from Alcon Laboratories, Inc.
The pressurizing of infusion source 14 is preferably performed by pressure cuff 12. More specifically, microprocessor 28 sends a control signal to open solenoid valve 42 via interface 106 and to close solenoid valves 44 and 46 via interfaces 108 and 110, respectively. Microprocessor 28 also sends a control signal to open proportional solenoid valve 40 via interface 104 so that manifold 30 supplies the appropriate amount of pressurized air to actuate pressure cuff 12. Pressure transducer 68 senses the pressure within gas line 82 and provides a corresponding signal to microprocessor 28 via interface 126. Solenoid valves 48-54 are initially open so that manifold 32 provides pressurized air to actuate actuators 56-62 to close fluid lines 72-78. Microprocessor 28 sends control signals to close solenoid valves 48-54 via interfaces 114-120. The closing of solenoid valves 48-54 actuates actuators 56-62 to open fluid lines 72-78. After all chambers and fluid lines are primed, microprocessor 28 closes actuators 56-62 and thus fluid lines 72-78. Alternatively, the pressuring of infusion source 14 may be performed solely via gravity.
After priming, a user then provides a desired intraocular pressure to microprocessor 28 via an input 134. Input 134 may be any suitable input device but is preferably a touch screen display or physical knob. Chamber 16b is preferably the initial active infusion chamber. Microprocessor 28 sends appropriate control signals to open solenoid valve 44 and to open proportional solenoid valve 36 (via interface 100) to provide an appropriate level of pressurized air to chamber 16b. Pressure transducer 64 senses the pressure within gas line 84 and provides a corresponding signal to microprocessor 28 via interface 124. Microprocessor 28 also sends an appropriate control signal to open actuator 60 and thus fluid line 78. Chamber 16b supplies pressurized fluid 140 to the eye via fluid lines 78 and 80 and surgical device 29. Flow sensor 22 measures the flow rate of fluid 140 and provides a corresponding signal to microprocessor 28 via interface 132. Microprocessor 28 calculates a predicted intraocular pressure using the signal from flow sensor 22 and empirically determined impedance information of microsurgical system 10. Microprocessor 28 then sends an appropriate feedback control signal to proportional solenoid valve 36 to maintain the predicted intraocular pressure at or near the desired intraocular pressure during all portions of the surgery.
Fluid level sensor 20 continuously monitors the decrease in the level of fluid 140 in chamber 16b during surgery and provides a corresponding signal to microprocessor 28 via interface 130. Microprocessor 28 performs adjustments to the air pressure provided to chamber 16b to accommodate for the difference in fluid head height as the level of fluid 140 decreases. When the level of fluid 140 in chamber 16b reaches a bottom limit level, microprocessor 28 closes solenoid valve 44 and actuator 60 and opens solenoid valve 46 and actuators 58 and 62. Chamber 16a is now the active infusion chamber. Microprocessor 28 sends an appropriate control signal to proportional solenoid valve 38 via interface 102 to provide an appropriate level of pressurized air to chamber 16a. Pressure transducer 66 senses the pressure within gas line 86 and provides a corresponding signal to microprocessor 28 via interface 122. Chamber 16a supplies pressurized fluid 140 to the eye via fluid lines 76 and 80 and surgical device 29. Flow sensor 22 measures the flow rate of fluid 140 and provides a corresponding signal to microprocessor 28 via interface 132. Microprocessor 28 calculates the predicted intraocular pressure as described above and the sends an appropriate feedback signal to proportional solenoid valve 38 to maintain the predicted intraocular pressure at or near the desired intraocular pressure during all portions of the surgery. Microprocessor 28 closes actuator 58 and fluid line 74 once chamber 16b is refilled with fluid 140.
Fluid level sensor 18 continuously monitors the decrease in the level of fluid 140 in chamber 16a during surgery and provides a corresponding signal to microprocessor 28 via interface 128. Microprocessor 28 performs adjustments to the air pressure provided to chamber 16a to accommodate for the difference in fluid head height as the level of fluid 140 decreases. When the level of fluid 140 in chamber 16a reaches a bottom limit level, microprocessor 28 switches chamber 16b to active infusion, makes chamber 16a inactive, and refills chamber 16a with fluid 140 via fluid line 72. This cycling between chambers 16b and 16a continues throughout the surgery.
Infusion source 14 is preferably monitored via a fluid level sensor (not shown) capable of providing a signal to microprocessor 28 via interface 112 when source 14 reaches a near empty limit. Chambers 16a and 16b also preferably each have a volume that enable infusion source 14 to be exchanged, when near empty, without interrupting the surgical procedure. More specifically, chambers 16a and 16b preferably each have a volume of about 30 cc. Such volume allows about two minutes for a near empty infusion source 14 to be exchanged during conditions of maximum flow (e.g. core vitrectomy). In addition, since fluid lines 72 and 74 are fluidly coupled to chambers 16a and 16b, respectively, at or near lower surface 16e, once infusion source 14 is exchanged all air bubbles within fluid lines 70, 72, and 74 will be automatically “scrubbed out” as the inactive chamber 16a or 16b refills, without the need for re-priming.
In the case of failure of either of chambers 16a or 16b, microprocessor 28 can preferably continue surgery with only one active chamber. In the case of failure of both chambers 16a and 16b, microprocessor 28 can preferably continue surgery using only infusion source 14.
From the above, it may be appreciated that the present invention provides an improved method of controlling intraocular pressure with a microsurgical system. The present invention is illustrated herein by example, and various modifications may be made by a person of ordinary skill in the art. For example, while the present invention is described above relative to controlling intraocular pressure in an ophthalmic microsurgical system, it is also applicable to controlling pressure within the operative tissue during other types of microsurgery.
It is believed that the operation and construction of the present invention will be apparent from the foregoing description. While the apparatus and methods shown or described above have been characterized as being preferred, various changes and modifications may be made therein without departing from the spirit and scope of the invention as defined in the following claims
This application is a divisional of U.S. application Ser. No. 11/237,568 filed Sep. 28, 2005 now U.S. Pat. No. 7,713,237.
Number | Name | Date | Kind |
---|---|---|---|
4475904 | Wang | Oct 1984 | A |
4713051 | Steppe et al. | Dec 1987 | A |
4750643 | Wortrich | Jun 1988 | A |
4758238 | Sundblom et al. | Jul 1988 | A |
4813927 | Morris et al. | Mar 1989 | A |
4832685 | Haines | May 1989 | A |
4900301 | Morris et al. | Feb 1990 | A |
4935005 | Haines | Jun 1990 | A |
4963131 | Wortrich | Oct 1990 | A |
5032111 | Morris et al. | Jul 1991 | A |
5041096 | Beuchat et al. | Aug 1991 | A |
5047009 | Morris et al. | Sep 1991 | A |
5098037 | Leffel et al. | Mar 1992 | A |
5106366 | Steppe | Apr 1992 | A |
5163900 | Wortrich | Nov 1992 | A |
5267956 | Beuchat | Dec 1993 | A |
5282787 | Wortrich | Feb 1994 | A |
D352106 | Fanney et al. | Nov 1994 | S |
5364342 | Beuchat et al. | Nov 1994 | A |
5499969 | Beuchat et al. | Mar 1996 | A |
D375553 | Creed et al. | Nov 1996 | S |
5582601 | Wortrich et al. | Dec 1996 | A |
5588815 | Zaleski, II | Dec 1996 | A |
5620312 | Hyman et al. | Apr 1997 | A |
D380550 | Dennewill et al. | Jul 1997 | S |
5643203 | Beiser et al. | Jul 1997 | A |
5676530 | Nazarifar | Oct 1997 | A |
5676650 | Grieshaber et al. | Oct 1997 | A |
5700240 | Barwick, Jr. et al. | Dec 1997 | A |
5747824 | Jung et al. | May 1998 | A |
5800396 | Fanney et al. | Sep 1998 | A |
5865764 | Moorhead | Feb 1999 | A |
5897524 | Wortrich et al. | Apr 1999 | A |
5899674 | Jung et al. | May 1999 | A |
6059544 | Jung et al. | May 2000 | A |
6261283 | Morgan et al. | Jul 2001 | B1 |
6293926 | Sorensen et al. | Sep 2001 | B1 |
6561999 | Nazarifar et al. | May 2003 | B1 |
6572349 | Sorensen et al. | Jun 2003 | B2 |
6579255 | Kadziauskas et al. | Jun 2003 | B2 |
6632214 | Morgan et al. | Oct 2003 | B2 |
6740074 | Morgan et al. | May 2004 | B2 |
6824525 | Nazarifar et al. | Nov 2004 | B2 |
6902542 | Gordon | Jun 2005 | B2 |
6962488 | Davis et al. | Nov 2005 | B2 |
20020019607 | Bui | Feb 2002 | A1 |
20020033370 | Bainbridge et al. | Mar 2002 | A1 |
20030050619 | Mooijman et al. | Mar 2003 | A1 |
20030108429 | Angelini et al. | Jun 2003 | A1 |
20030225363 | Gordon et al. | Dec 2003 | A1 |
20040116911 | Kadziauskas et al. | Jun 2004 | A1 |
20040253129 | Sorensen et al. | Dec 2004 | A1 |
20050065462 | Nazarifar et al. | Mar 2005 | A1 |
Number | Date | Country |
---|---|---|
1068572 | Dec 1979 | CA |
1068574 | Dec 1979 | CA |
18752574 | May 2000 | DE |
0776670 | Sep 2001 | EP |
1356835 | Oct 2003 | EP |
1612532 | Apr 2006 | EP |
03047652 | Jun 2003 | WO |
03047653 | Jun 2003 | WO |
03047654 | Jun 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20100228199 A1 | Sep 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11237568 | Sep 2005 | US |
Child | 12750787 | US |